Showing results (161-170 of 217) with videos related to
Sort By:
Pageof 22
Cancer Medicine|June 15, 2019
Risk stratification of ER-positive breast cancer patients: A multi-institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26Bradley M Turner, Mary Ann Gimenez-Sanders, Armen Soukiazian, et al.Diagnostic Pathology|October 24, 2008
Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH)Hiroaki Nitta, Beatrice Hauss-Wegrzyniak, Megan Lehrkamp, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 5, 2011
HER2 amplification, overexpression and score criteria in esophageal adenocarcinomaYingchuan Hu, Santhoshi Bandla, Tony E Godfrey, et al.Journal of the National Cancer Institute|October 24, 2012
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissuesVeronique M Neumeister, Valsamo Anagnostou, Summar Siddiqui, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|November 25, 2014
Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic timeMaria Vassilakopoulou, Fabio Parisi, Summar Siddiqui, et al.Breast Cancer : Basic and Clinical Research|August 11, 2010
The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell LinesKristina Subik, Jin-Feng Lee, Laurie Baxter, et al.American Journal of Clinical Pathology|June 2, 2023
HER2 in uterine serous carcinoma: Current state and clinical perspectivesJanira M Navarro Sanchez, Brian S Finkelman, Bradley M Turner, et al.Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.American Journal of Clinical Pathology|December 2, 2019
Frequency, Clinicopathologic Characteristics, and Follow-up of HER2-Positive Nonpleomorphic Invasive Lobular Carcinoma of the BreastHuina Zhang, Ioana Moisini, Rana M Ajabnoor, et al.The Journal of Biological Chemistry|July 31, 2008
Breast cancer metastasis suppressor-1 differentially modulates growth factor signalingKedar S Vaidya, Sitaram Harihar, Pushkar A Phadke, et al.Pageof 22